Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01468168 · ClinicalTrials.gov registry record · Phase 2
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
A Phase 2 study, sponsored by Santen.
- Completed
- Registry status
- Phase 2
- Development phase
- 183
- Enrollment target
NCT01468168: Completed Phase 2 study, sponsored by Santen.
NCT01468168 is a Phase 2 study that has completed, run by Santen. The registered enrollment target is 183 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (38% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01468168, a Phase 2 study, has completed, sponsored by Santen.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 183 participants
- Enrollment target
Study Summary
To investigate the safety and efficacy of DE-101 to improve the signs and symptoms in dry-eye disease.
Interventions
- DRUG DE-101 Ophthalmic Suspension
- DRUG DE-101 Ophthalmic Suspension Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-11 |
| Phase | Phase 2 |
What the finished NCT01468168 record still lists
NCT01468168 is an interventional study that assigns participants to a tested intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (38% higher).
The record links to 0 conditions, and to 2 interventions - of which DE-101 Ophthalmic Suspension is the first listed.
NCT01468168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01468168 about?
NCT01468168 is a clinical study titled "A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients". To investigate the safety and efficacy of DE-101 to improve the signs and symptoms in dry-eye disease.
What is the current status of trial NCT01468168?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 183 participants. The study started on 2011-10. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01468168?
The interventions under investigation include: DE-101 Ophthalmic Suspension (DRUG), DE-101 Ophthalmic Suspension Vehicle (DRUG).
Who is sponsoring clinical trial NCT01468168?
This trial is sponsored by Santen, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01468168's enrollment target sits among peer trials
183 363rd of 2000 higher than 1,638 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia